Kidney Cancer

Latest News

Phase 1/2 trial launches of CAR T cell therapy for ccRCC
Phase 1/2 trial launches of CAR T cell therapy for ccRCC

November 20th 2024

Initial results on ADI-270 are anticipated for the first half of 2025.

ALLO-316 shows encouraging CAR activity in advanced ccRCC
ALLO-316 shows encouraging CAR activity in advanced ccRCC

November 8th 2024

Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma
Casdatifan demonstrates encouraging clinical activity in renal cell carcinoma

November 4th 2024

FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCC
FDA grants Regenerative Medicine Advanced Therapy designation to ALLO-316 for RCC

October 29th 2024

Pazopanib plus bevacizumab shows promising phase 2 efficacy in ccRCC
Pazopanib plus bevacizumab shows promising phase 2 efficacy in ccRCC

September 25th 2024

Video Series
Video Interviews
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.